Urothelial Carcinoma Bladder Clinical Trials

16 recruiting

Urothelial Carcinoma Bladder Trials at a Glance

16 actively recruiting trials for urothelial carcinoma bladder are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 1 with 6 trials, with the heaviest enrollment activity in Miami, Washington D.C., and Baltimore. Lead sponsors running urothelial carcinoma bladder studies include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Brown University, and Aktis Oncology, Inc..

Browse urothelial carcinoma bladder trials by phase

Treatments under study

About Urothelial Carcinoma Bladder Clinical Trials

Looking for clinical trials for Urothelial Carcinoma Bladder? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Urothelial Carcinoma Bladder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Urothelial Carcinoma Bladder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity

Urothelial Carcinoma Bladder
Ludwig-Maximilians - University of Munich146 enrolled1 locationNCT06806059
Recruiting
Phase 1

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Urothelial Carcinoma Bladder
Aktis Oncology, Inc.150 enrolled9 locationsNCT07020117
Recruiting
Phase 1

A Study of VET3-TGI in Patients With Solid Tumors

Cervical CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics60 enrolled7 locationsNCT06444815
Recruiting
Phase 3

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Bladder CancerUrothelial Carcinoma BladderNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc.540 enrolled6 locationsNCT05037279
Recruiting

Bladder EpiCheck European Haematuria Study

Urothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterHematuria+2 more
Nucleix Ltd.800 enrolled5 locationsNCT06818136
Recruiting
Phase 2

Renal Retention in High Grade Upper Tract Urothelial Cancer

Bladder CancerUrothelial Carcinoma BladderHigh Grade Urothelial Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins20 enrolled2 locationsNCT05656235
Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

CancerBladder CancerKidney Cancer+3 more
Elephas416 enrolled12 locationsNCT05520099
Recruiting
Phase 1

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Gastric CancerCervical CancerCancer+7 more
Rondo Therapeutics149 enrolled2 locationsNCT07218003
Recruiting
Phase 2

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

Urothelial Carcinoma Bladder
University of Florida147 enrolled1 locationNCT06184516
Recruiting
Phase 1Phase 2

Intervention of Bladder Cancer by CAR-T

Bladder CancerUrothelial Carcinoma Bladder
Shenzhen Geno-Immune Medical Institute20 enrolled2 locationsNCT03185468
Recruiting
Phase 2

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Urothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Urethra+1 more
Nagoya University43 enrolled1 locationNCT06983210
Recruiting
Phase 2

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Bladder CancerUrothelial Carcinoma BladderSmall Cell Neuroendocrine Carcinoma of Bladder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins63 enrolled2 locationsNCT05312671
Recruiting
Phase 1

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Bladder CancerUrothelial Carcinoma Bladder
Abramson Cancer Center at Penn Medicine10 enrolled1 locationNCT06586255
Recruiting
Phase 2

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Mabwell (Shanghai) Bioscience Co., Ltd.60 enrolled2 locationsNCT06823427
Recruiting
Phase 1

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Urothelial Carcinoma BladderAndrogen Receptor Positive
Brown University32 enrolled1 locationNCT05839119
Recruiting
Not Applicable

En Bloc Bladder Tumor Resection: Prospective Randomized Study

Bladder CancerUrothelial Carcinoma Bladder
Fundacio Puigvert300 enrolled1 locationNCT04712201